Director Robin L. Smith resigns from Celularity board effective Dec. 24, 2023

Celularity Inc

Robin L. Smith, MD, a Class II director, resigned from the board on December 24, 2023.
Resignation was not due to any disagreement with Celularity on operations, policies, or practices.
No replacement director has been announced as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Robin L. Smith, MD

Class II member of the board of directors

CELU · Celularity Inc

Effective: 2023-12-24
Filed: December 29, 2023, 6:59 PM ET

On December 24, 2023, Robin L. Smith, MD, a Class II member of the board of directors of Celularity Inc., or Celularity, notified the board of directors of her intention to resign as a member of the board effective December 24, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robin L. Smith, MD resigned as Class II member of the board of directors at Celularity Inc.

Action: resigned
Role: Class II member of the board of directors

Exact text from the filing

On December 24, 2023, Robin L. Smith, MD, a Class II member of the board of directors of Celularity Inc., or Celularity, notified the board of directors of her intention to resign as a member of the board effective December 24, 2023.

View on SEC.gov

Celularity Inc filing history →

Source: SEC EDGAR

accession 0000950170-23-073894

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.